Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca initiates CALAVI clinical trial with Calquence against COVID-19

worldpharmanewsApril 15, 2020

Tag: AstraZeneca , Calquence , COVID-19 , CALAVI , BTK Inhibition

PharmaSources Customer Service